alexa Multidisciplinary Management of a Rare Case of Esophageal Adenocarcinoma with Cardiac, Pulmonary, Liver, Adrenal Gland and Brain Metastasis | OMICS International| Abstract

Journal of Tumor Research

  • Case Report   
  • J Tumor Res 2016, Vol 1(1): 1

Multidisciplinary Management of a Rare Case of Esophageal Adenocarcinoma with Cardiac, Pulmonary, Liver, Adrenal Gland and Brain Metastasis

Tingrui Wang1, Zonghui Ding2, Sabyasachi Roy1, Richard Manch3 and Jue Wang3*
1Department of Internal Medicine, St. Joseph’s Hospital and Medical Center, Phoenix, USA
2Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, USA
3The University of Arizona Cancer Center, at St. Joseph’s Hospital and Medical Center, Phoenix, USA
*Corresponding Author : Jue Wang, The University of Arizona Cancer Center, At St. Joseph’s Hospital And Medical Center 625 N 6th Street, Phoenix, USA, Tel: 602-406-8222, Email: [email protected]

Received Date: Mar 15, 2016 / Accepted Date: Apr 19, 2016 / Published Date: Apr 25, 2016

Abstract

We report the case of a 48-year-old gentleman affected by diffuse metastatic gastroesophageal junction (GEJ). Positron emission tomography (PET) scan demonstrated diffuse metastatic disease involving brain, heart, lungs, liver and adrenal glands. Transthoracic echocardiogram showed a mass in the left ventricular apex measuring 2.46 cm × 1.32 cm. Cardiac Magnetic resonance imaging (MRI) showed 2.3 cm mass in the apex of the left ventricle. Peripheral blood circulating tumor DNA (ctDNA) analysis confirmed dissemination of cancer and showed mutations in TP53, AR, PIK3CA, and Erbb2 amplification. Combination chemotherapy consisting of trastuzumab, capecitabine and oxaliplatin was initiated with a significant reduction of tumor markers: CEA from 60.7 to 19.7 ng/mL (67.5%) and CA19-9 from 2104 to 139 Units/mL (93.4%). A repeated PET scan demonstrated resolution of FDG avidity of left ventricle/pericardium, decreased avidity and size of adrenal gland masses, lung nodules and primary esophageal mass. We reviewed and summarized the recent literatures regarding the clinical presentations, diagnostic tools, tumor histology, treatment modalities and clinical prognosis of cardiac metastases from esophageal cancer. This report also highlights the potential role of ctDNA as a cost effective marker in the management of metastatic esophageal cancer.

Keywords: Esophageal adenocarcinoma; Adenocarcinoma of the gastroesophageal junction (GEJ); Multidisciplinary team; Cardiac metastasis; Circulating tumor DNA (ctDNA)

Citation: Wang T, Ding Z, Roy S, Manch R, Wang J (2016) Multidisciplinary Management of a Rare Case of Esophageal Adenocarcinoma with Cardiac, Pulmonary, Liver, Adrenal Gland and Brain Metastasis. J Tumor Res 1: 106.

Copyright: ©2016 Wang T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment
Share This Article
Recommended Conferences
Viewmore
Article Usage
  • Total views: 8791
  • [From(publication date): 4-2015 - Jul 21, 2018]
  • Breakdown by view type
  • HTML page views: 8708
  • PDF downloads: 83
Leave Your Message 24x7